Experimental investigations with metrizamide with relevance to the myelographic use

Area of Science:

• Neurology
• Radiology
• Toxicology

Background:

• Metrizamide (Amipaque) is a contrast agent used in neuroradiology.
• Previous studies suggested low toxicity of metrizamide in the subarachnoid space.
• Potential interactions with neuroleptic drugs require further investigation.

Purpose of the Study:

• To evaluate the toxicity of metrizamide in animal models.
• To confirm the interaction between metrizamide and neuroleptic drugs.
• To assess the risk of adhesive arachnoiditis following clinical doses of metrizamide.

Main Methods:

• Animal experiments were conducted using metrizamide in the subarachnoid space.
• The interaction between metrizamide and neuroleptic drugs was studied.
• The potential for metrizamide to induce adhesive arachnoiditis was assessed.

Main Results:

• Animal experiments substantiated the previously demonstrated low toxicity of metrizamide.
• The interaction between metrizamide and neuroleptic drugs was confirmed.
• The induction of adhesive arachnoiditis by clinical doses of metrizamide remains undetermined.

Conclusions:

• Metrizamide exhibits low toxicity in animal models when administered in the subarachnoid space.
• Metrizamide interacts with neuroleptic drugs.
• The potential for metrizamide to cause adhesive arachnoiditis at clinical doses requires further clinical investigation.